Slides on Precision Management of Late Endocrine Effects in Cancer Survivors

Learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments, including hypothalamic pituitary dysfunction, thyroid disorders, obesity and diabetes mellitus.
Wassim Chemaitilly, MD
Laurie E. Cohen, MD
Danielle N. Friedman, MD, MS
Steven G. Waguespack, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.61 MB
Released: March 18, 2021

Acknowledgements

Provided by the Endocrine Society

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Steven Waguespack, MD, on hypothyroidism after immune checkpoint inhibitors, MIBG treatment, or mitotane, and the mechanism of hyperthyroidism in cancer survivors from Clinical Care Options (CCO)

Steven G. Waguespack, MD Released: April 26, 2021

Laurie Cohen, MD, on when and how to retest for GH deficiency, how soon to start GH replacement in cancer survivors from Clinical Care Options (CCO)

Laurie E. Cohen, MD Released: April 22, 2021

Danielle Friedman, MD, on adipose dysfunction, insulinopenia, obesity, and diabetes after irradiation in cancer survivors

Danielle N. Friedman, MD, MS Released: April 22, 2021

Webcast from ENDO 2021, learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments

Wassim Chemaitilly, MD Laurie E. Cohen, MD Danielle N. Friedman, MD, MS Steven G. Waguespack, MD ABIM MOC: maximum of 1.5 Medical Knowledge MOC point(s) Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: March 22, 2021 Expired: No longer available for credit

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings